Conference Coverage: ESMO 2025 – Focus on Gastrointestinal Malignancies
A roundtable discussion, featuring 6 leading GI cancer experts from the US and Europe, that reviews key updates from ESMO 2025, focusing on the latest research and therapeutic advances and their application in clinical decision-making, with postmeeting insights and actionable recommendations.
Faculty Chair
Tanios S. Bekaii-Saab, MD, FACP
Mayo Clinic, Phoenix, AZ, USA
FACULTY MEMBERS
Dirk Arnold, MD, PhD
Asklepios Tumor Center Hamburg, Germany
Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France
Wungki Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Nataliya Uboha, MD, PhD
University of Wisconsin—Madison, USA
Alan Venook, MD, FASCO
Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Colorectal Cancer
- Rectal Cancer
- Gastric, Esophageal, and Gastroesophageal Junction Cancers
- Pancreatic Cancer and Biliary Tract Cancer
- Hepatocellular Carcinoma
